Pirtobrutinib in heavily pre-treated richter transformation: Updated efficacy and safety results with 18-month median survival follow-up from the phase 1/2 BRUIN study Meeting Abstract


Authors: Wierda, W. G.; Shah, N. N.; Cheah, C. Y.; Lewis, D.; Hoffman, M. S.; Coombs, C. C.; Lamanna, N.; Shuo, M. A.; Jagadeesh, D.; Munir, T.; Wang, Y.; Eyre, T. A.; Rhodes, J.; Mckinney, M.; Lech-Maranda, E.; Tam, C. S.; Jurczak, W.; Izutsu, K.; Alencar, A.; Patel, M. R.; Seymour, J. F.; Woyach, J.; Roeker, L. E.; Thompson, P. A.; Abada, P.; Ho, C.; Marella, N.; Wang, C.; Ruppert, A. S.; Nair, B.; Liu, H.; Tsai, D. E.; Ghia, P.; Al-Sawaf, O.
Abstract Title: Pirtobrutinib in heavily pre-treated richter transformation: Updated efficacy and safety results with 18-month median survival follow-up from the phase 1/2 BRUIN study
Meeting Title: 36. Deutscher Krebskongress - Fortschritt gemeinsam gestalten
Journal Title: Oncology Research and Treatment
Volume: 47
Issue: Suppl. 1
Meeting Dates: 2024 Feb 21-24
Meeting Location: Berlin, Germany
ISSN: 2296-5270
Publisher: S. Karger AG  
Date Published: 2024-02-01
Start Page: 120
End Page: 121
Language: English
ACCESSION: WOS:001332646400285
PROVIDER: wos
DOI: 10.1159/000535363
Notes: Meeting Abstract: 578 -- 'The 36th German Cancer Congress - Building Progress Together' -- Located in the section 'Hematooncology including Bone marrow transplantation, Lymphoma, Plasmocytoma' -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lindsey Elizabeth Roeker
    132 Roeker